(Reuters) -The U.S. Centers for Disease Control and Prevention said on Wednesday it anticipates voting on the pediatric use of Measles, Mumps, Rubella, and Varicella (MMRV) vaccines and hepatitis B vaccines during a two-day meeting of experts scheduled for September 18-19, according to an advisory draft.
(Reporting by Gursimran Kaur in Bengaluru; Editing by Jacqueline Wong)
Brought to you by www.srnnews.com
